FDA warns of possible mould contamination as New Jersey pharmacy recalls all compounded drugs

WASHINGTON – The Food and Drug Administration is warning doctors and hospital managers about a nationwide recall of all drugs made by a New Jersey compounding pharmacy because they may be contaminated with mould.

The recalled products from Med Prep Consulting Inc. include dozens of drugs packaged in infusion bags, plastic syringes and glass vials distributed to regional hospitals.

The Tinton Falls, N.J.-based company said Saturday that mould was found in five bags of magnesium sulfate products dispensed to a Connecticut hospital.

No infections have been reported to date, but the FDA says it is working with officials in New Jersey and Connecticut to determine the scope of contamination.

A tainted steroid distributed by an unrelated pharmacy last year has killed 50 people and sickened more than 720 nationwide.